Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huoluo Oil is a topical analgesic and anti-inflammatory Traditional Chinese Medicine (TCM) formulation developed by Hong Kong Aomei Pharmaceutical. It is primarily indicated for the relief of pain associated with acute soft tissue contusions, muscle aches, and joint stiffness. The oil typically contains a synergistic blend of active ingredients including methyl salicylate, menthol, camphor, eucalyptus oil, turpentine oil, and cinnamon oil. These components act as counter-irritants that stimulate local blood circulation and modulate pain perception by interacting with various thermoreceptors such as TRPM8 and TRPV1. The preparation provides a cooling sensation followed by warmth, which helps to alleviate localized pain and reduce inflammation in the musculoskeletal system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huoluo Oil.